These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women. Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L. Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480 [Abstract] [Full Text] [Related]
3. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention. Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V. Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460 [Abstract] [Full Text] [Related]
4. A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study. Alcaide ML, Chisembele M, Malupande E, Rodriguez VJ, Fischl MA, Arheart K, Jones DL. BMC Infect Dis; 2017 May 12; 17(1):338. PubMed ID: 28494795 [Abstract] [Full Text] [Related]
9. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC, Chen HY, Landay A. Clin Vaccine Immunol; 2007 Sep 12; 14(9):1102-7. PubMed ID: 17671228 [Abstract] [Full Text] [Related]
10. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K, Gamieldien H, Williamson C, Mckinnon LR, Walzl G, Abdool Karim Q, Abdool Karim SS, Passmore JA. Sex Transm Infect; 2014 Dec 12; 90(8):580-7. PubMed ID: 25107710 [Abstract] [Full Text] [Related]
12. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. Mitchell CM, Balkus J, Agnew KJ, Cohn S, Luque A, Lawler R, Coombs RW, Hitti JE. AIDS Res Hum Retroviruses; 2008 May 12; 24(5):667-71. PubMed ID: 18462081 [Abstract] [Full Text] [Related]
13. Predictors of bacterial vaginosis in adolescent women who douche. Schwebke JR, Desmond RA, Oh MK. Sex Transm Dis; 2004 Jul 12; 31(7):433-6. PubMed ID: 15215700 [Abstract] [Full Text] [Related]
14. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Hutchinson KB, Kip KE, Ness RB, Gynecologic Infection Follow-Through (GIFT) Investigators. Sex Transm Dis; 2007 Sep 12; 34(9):671-5. PubMed ID: 17413534 [Abstract] [Full Text] [Related]
15. Frequent douching and clinical outcomes among HIV-infected women. Clark RA, Theall KP, Amedee AM, Kissinger PJ. Sex Transm Dis; 2007 Dec 12; 34(12):985-90. PubMed ID: 17621248 [Abstract] [Full Text] [Related]
16. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. Fichorova RN, Morrison CS, Chen PL, Yamamoto HS, Govender Y, Junaid D, Ryan S, Kwok C, Chipato T, Salata RA, Doncel GF. PLoS One; 2020 Dec 12; 15(1):e0224359. PubMed ID: 31914129 [Abstract] [Full Text] [Related]
17. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM. Am J Obstet Gynecol; 2008 Jun 12; 198(6):628.e1-7. PubMed ID: 18295180 [Abstract] [Full Text] [Related]
18. Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon. Kamga YM, Ngunde JP, Akoachere JKT. BMC Pregnancy Childbirth; 2019 May 10; 19(1):166. PubMed ID: 31077161 [Abstract] [Full Text] [Related]
19. Genital inflammation and the risk of HIV acquisition in women. Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. Clin Infect Dis; 2015 Jul 15; 61(2):260-9. PubMed ID: 25900168 [Abstract] [Full Text] [Related]
20. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. J Infect Dis; 2005 Jan 01; 191(1):25-32. PubMed ID: 15592999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]